In addition, IU1 as a single agent, slightly reduced the mouse tumor burden and improved survival rates, while the combined IU1 and anti-PD-1 treatment significantly reduced tumor weights and extended the survival of the mice (Fig. 6d–f and Supplementary Fig. 6b, c). The gene discussed is PDCD1; the disease is neoplasm.